Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01802437 · ClinicalTrials.gov registry record · Phase 1
An Adaptive Treatment Strategy for Adolescent Depression
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT01802437 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 40 participants.
The verdict
NCT01802437, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of the study is: 1. to find out how long teenagers getting talk therapy (interpersonal psychotherapy) for depression should get therapy before the therapist decides whether or not the teenager is improving enough, and 2. to compare two ways of providing treatment to teenagers who have not improved enough.
Interventions
- DRUG Fluoxetine
- BEHAVIORAL Increased Dose of Interpersonal Psychotherapy
- BEHAVIORAL Continue to Receive Initial Dose of Interpersonal Psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-11 |
| Est. Completion | 2016-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01802437
The ClinicalTrials.gov registry entry for NCT01802437 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Fluoxetine is the first listed.
NCT01802437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01802437 about?
NCT01802437 is a clinical study titled "An Adaptive Treatment Strategy for Adolescent Depression". The purpose of the study is: 1. to find out how long teenagers getting talk therapy (interpersonal psychotherapy) for depression should get therapy before the therapist decides whether or not the teenager is improving enough, and 2. to compare two ways of providing treatment to teenagers who have n...
What is the current status of trial NCT01802437?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2010-11. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01802437?
The interventions under investigation include: Fluoxetine (DRUG), Increased Dose of Interpersonal Psychotherapy (BEHAVIORAL), Continue to Receive Initial Dose of Interpersonal Psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01802437?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.